Group 1 - The core index of the biotechnology sector, the Biotechnology Index (970038), closed at 2258.05 points, reflecting a 1.64% increase with a trading volume of 30.954 billion yuan and a turnover rate of 2.47% [1] - Among the constituent stocks of the Biotechnology Index, 40 stocks experienced an increase, with Dean Diagnostics leading the rise at a 20.0% increase, while 10 stocks saw a decline, with Meihao Medical leading the drop at an 11.81% decrease [1] Group 2 - In terms of capital flow, the net inflow of main funds into the Biotechnology Index constituents totaled 110 million yuan, while speculative funds saw a net outflow of 416 million yuan, and retail investors had a net inflow of 306 million yuan [2] - Detailed capital flow information for the constituent stocks is available in the accompanying table [2]

Core Viewpoint - The Biotech Economy Index (970038) closed at 2117.66 points, down 0.2%, with a trading volume of 10.477 billion yuan and a turnover rate of 0.98% on December 4 [1] Group 1: Index Performance - The index had 17 stocks that rose, with Xinlitai leading at a 3.4% increase, while 33 stocks fell, with Hualan Biological leading the decline at 5.75% [1] - The top ten constituent stocks of the Biotech Economy Index are primarily in the pharmaceutical and biotechnology sectors, with Mindray Medical holding the largest weight at 12.58% and a market capitalization of 242.49 billion yuan [1] Group 2: Capital Flow - On the same day, the main funds saw a net outflow of 459 million yuan, while retail investors had a net inflow of 428 million yuan [3] - The detailed capital flow for specific stocks shows that Hongri Pharmaceutical had a net inflow of 38.07 million yuan from main funds, while it experienced a net outflow of 59.67 million yuan from retail investors [3] Group 3: Index Adjustment - The Biotech Economy Index underwent adjustments, adding 9 new stocks and removing 9 stocks [4] - New additions include Chaoyan Co., Kanghua Biotechnology, and Yingke Medical, while notable removals include Wens Foodstuffs and Hongri Pharmaceutical [4]

Core Insights - The Biotech Index (970038) closed at 2252.2 points, down 0.61%, with a trading volume of 20.2 billion yuan and a turnover rate of 1.44% [1] - Among the index constituents, 17 stocks rose while 31 stocks fell, with Hualan Vaccine leading the gainers at a 7.22% increase and Deep Technology leading the decliners at a 5.43% decrease [1] Index Constituents Summary - The top ten constituents of the Biotech Index include: - Mindray Medical (sz300760) with a weight of 12.58%, latest price at 207.70, and a slight decrease of 0.24% [1] - Changchun High-tech (sz000661) with a weight of 4.87%, latest price at 104.55, and a marginal increase of 0.09% [1] - Ten Years Aoshi (sz002252) with a weight of 4.74%, latest price at 6.87, down 0.43% [1] - Kanglong Chemical (sz300759) with a weight of 4.55%, latest price at 31.48, down 0.35% [1] - Tigermed (sz300347) with a weight of 4.54%, latest price at 57.90, down 2.08% [1] - Deep Technology (sz000021) with a weight of 4.16%, latest price at 24.74, down 5.43% [1] - Muyuan Foods (sz002714) with a weight of 3.62%, latest price at 49.87, down 1.38% [1] - Lepu Medical (sz300003) with a weight of 3.19%, latest price at 16.78, down 0.42% [1] - Aimeike (sz300896) with a weight of 3.16%, latest price at 157.61, down 1.25% [1] - Yufu Medical (sz002223) with a weight of 3.07%, latest price at 36.21, down 0.77% [1] Capital Flow Analysis - The Biotech Index constituents experienced a net outflow of 9.52 billion yuan from institutional investors, while retail investors saw a net inflow of 5.6 billion yuan [1] - Notable capital flows include: - Changchun High-tech with a net inflow of 48.81 million yuan from institutional investors [2] - Hualan Vaccine with a net inflow of 27.99 million yuan from institutional investors [2] - Lepu Medical with a net inflow of 9.86 million yuan from institutional investors [2]